- Filed
- May 1, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 29, 2025 | 216.29M sh |
| Cash And Equivalents | Q1 2025 · Mar 29, 2025 | $181.33M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $196.59M |
| Current Liabilities | Q1 2025 · Mar 29, 2025 | $294.37M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $312.98M |
| Total Liabilities | Q1 2025 · Mar 29, 2025 | $1.55B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $1.57B |
| Current Assets | Q1 2025 · Mar 29, 2025 | $773.5M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $766.97M |
| Total Assets | Q1 2025 · Mar 29, 2025 | $2.98B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.99B |
| Shares Diluted | Q1 2025 · Mar 30, 2024 | 221.08M sh |
| Stock Repurchased | Q1 2025 · Mar 30, 2024 | $355K |
| Capex restated | Q1 2025 · Mar 30, 2024 | $5.42M |
| Operating Cash Flow | Q1 2025 · Mar 30, 2024 | −$77.2M |
| Stockholders Equity | Q1 2025 · Mar 30, 2024 | $1.32B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.31B |
| Eps Diluted | Q1 2025 · Mar 30, 2024 | $0.04 |
| Eps Basic | Q1 2025 · Mar 30, 2024 | $0.05 |
| Sga Expense | Q1 2025 · Mar 30, 2024 | $60.01M |
| Rd Expense | Q1 2025 · Mar 30, 2024 | $6.3M |
| Net Income | Q1 2025 · Mar 30, 2024 | $9.84M |
| Operating Income | Q1 2025 · Mar 30, 2024 | $30.86M |
| Gross Profit | Q1 2025 · Mar 30, 2024 | $104.58M |
| Cost Of Revenue | Q1 2025 · Mar 30, 2024 | $107.99M |
| Revenue | Q1 2025 · Mar 30, 2024 | $212.57M |